Nagpur-based diagnostics startup Erlysign’s first test kit, an easy and quick way to screen for oral cancer through a saliva sample, is undergoing clinical trials.

In India, cancer is the most common cause of death in adults. While cancer can affect any part of the body, oral cancer is among the top three common types in the country.

Lumos, a premier Healthcare speed scaling program, today announced the addition of Onward Assist and ErlySign to its speed scaling program.

Cancer is a complex disease of worldwide concern. Along with an improvement in outcomes, early and sensitive detection of cancer and cancer biomarkers can facilitate

Shubhendra Singh Thakur, a graduate in Biology who holds a specialisation in Design and Interpretation of Clinical Trials has always been a tech lover.

Cancer is devastating for many. With World Cancer Day just gone by, we bring you beacons of hope that are trying to make a difference in the lives of cancer patients.